52 results on '"Redell, Michele S."'
Search Results
2. 1701. Trends in Invasive Candidiasis in Children with Hematologic Malignancies: Increased Risk of Dissemination with Non-albicans Candida
3. ALK Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature
4. Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated
5. Improved Relapse Prediction in Pediatric Acute Myeloid Leukemia By Deconvolving Lineage-Specific and Cancer-Specific Features in Single-Cell Data
6. Development of a Pediatric AML Patient Derived Xenograft Program
7. Single-Cell Map of Childhood Acute Myeloid Leukaemia Using Variational Auto-Encoders
8. IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report
9. Abstract 3479: UBTF tandem duplications (UBTF-TD) in childhood AML: Enrichment in FLT3-ITD and association with clinical outcome
10. Comparison of the Transcriptomic Signatures in Pediatric and Adult CML
11. Cite-Seq Reveals Distinct Patterns and Potential Mechanisms of Relapse in Pediatric AML
12. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration
13. Introduction to the Special Issue on Pediatric Acute Myeloid Leukemia: Current Management and Future Directions
14. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia
15. Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic–inorganic inhibitors
16. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation
17. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis
18. Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group
19. Abstract 3550: Lipid rafts contribute to ligand-induced signaling and survival in pediatric AML
20. Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia
21. Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children’s Oncology Group report
22. Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance
23. Interleukin-6 Levels Predict Relapse Free Survival in Pediatric AML and Suggest a Mechanism of Chemotherapy Resistance
24. Rapid Infusion of Rituximab Is Well Tolerated in Children with Hematologic, Oncologic, and Rheumatologic Disorders
25. Differential Expression of Adhesion Molecule Receptors May Influence Bone Marrow Microenvironment-Mediated Protection of Leukemia-Initiating Cells (LICs) in Infant MLL-rearranged (MLL-R) Acute Lymphoblastic Leukemia (ALL)
26. The Bone Marrow Environment Promotes Resistance to Mitoxantrone and Etoposide By Distinct Mechanisms in Pediatric AML
27. A STAT3 decoy lures AML out of hiding
28. Assessing the intracellular fate of rhodium(ii) complexes
29. Poorer Relapse-Free Survival in Hispanic Children Diagnosed with Acute Myeloid Leukemia Compared with Non-Hispanics: A Texas Single Institution Experience
30. A Novel STAT3 Inhibitor Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia That Incorporate the Stromal Environment
31. Rhodium(II) Proximity‐Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti‐Leukemia Activity
32. Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity
33. Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia
34. Stromal CYR61 Confers Resistance to Mitoxantrone Via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukemia
35. CD123-Engager T Cells As a Novel Immunotherapeutic for AML
36. Abstract 4206: Increased responsiveness to ligand stimulation of the STAT pathway at relapse in acute myelogenous leukemia
37. Cytogenetically cryptic and FISH-negative PML/RARA rearrangement in acute promyelocytic leukemia detected only by PCR: an exceedingly rare phenomenon
38. Bone Marrow Stromal Cells Enhance DNA Damage Signaling Independent Of Stat3 Activation In Pediatric AML
39. Abstract 4962: Stroma-induced molecules and chemotherapy resistance in acute myeloid leukemia cells.
40. FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report
41. Intestinal perforation after treatment of Burkitt's lymphoma: Case report and review of the literature
42. Synthesis, activity and metabolic stability of non-ribose containing inhibitors of histone methyltransferase DOT1L
43. Increased Responsiveness to Ligand Stimulation of the STAT Pathway At Relapse in Acute Myelogenous Leukemia
44. Stroma-Mediated Chemotherapy Resistance in Acute Myeloid Leukemia Cells
45. FACS Analysis of Stat3/5 Signaling Reveals Ligand Sensitivity As a Significant Prognostic Factor in Pediatric AML: A Children's Oncology Group Report
46. Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor
47. Abstract 2908: Multiparameter FACS analysis of Stat3 and Stat5 signaling in pediatric AML samples
48. Multiparameter FACS Analysis of G-CSF and IL-6 Signaling through Stat3 and Stat5 In Primary Pediatric AML Samples.
49. Abstract 1791: Stat3 signaling in acute myeloid leukemia: Ligand-dependent and -independent activation, impact on prognosis, and induction of apoptosis by a novel Stat3 inhibitor
50. Stat3 Isoforms, α and β, Demonstrate Distinct Intracellular Dynamics with Prolonged Nuclear Retention of Stat3β Mapping to Its Unique C-terminal End
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.